勘误：CHK1在乳腺癌靶向治疗中的作用随雌激素受体和孕激素受体状态而变化：勘误。
Erratum: The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer : Erratum.
作者信息
Xu Wei, Huang Minghua, Guo Jia, Zhang Huiting, Wang Depeng, Liu Tiantian, Liu Haiting, Chen Shiming, Gao Peng, Mu Kun
机构信息
Department of Pathology, School of Basic Medical Sciences, Shandong University, Jinan, 250012, China.
Department of Respiratory and Critical Care Medicine, The second affiliated Hospital of Nanchang University, Nanchang, 330006, China.
出版信息
Int J Biol Sci. 2021 Feb 20;17(3):911-912. doi: 10.7150/ijbs.58372. eCollection 2021.
Abstract
[This corrects the article DOI: 10.7150/ijbs.41627.].
摘要
[本文更正了文章的数字对象标识符：10.7150/ijbs.41627。]
相似文献
1
Erratum: The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer : Erratum.勘误：CHK1在乳腺癌靶向治疗中的作用随雌激素受体和孕激素受体状态而变化：勘误。
Int J Biol Sci. 2021 Feb 20;17(3):911-912. doi: 10.7150/ijbs.58372. eCollection 2021.
2
Erratum: GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway: Erratum.勘误：GALNT6通过β-连环蛋白/MUC1-C信号通路促进乳腺癌细胞的致瘤性和转移：勘误。
Int J Biol Sci. 2021 Nov 11;17(15):4517. doi: 10.7150/ijbs.67971. eCollection 2021.
3
Erratum: A Long Non-coding RNA Lnc712 Regulates Breast Cancer Cell Proliferation: Erratum.勘误：一种长链非编码RNA Lnc712调节乳腺癌细胞增殖：勘误。
Int J Biol Sci. 2023 Jan 5;19(3):831. doi: 10.7150/ijbs.81665. eCollection 2023.
4
Erratum: Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum.勘误：Cx43缺陷通过c-Src/PI3K/Akt途径赋予乳腺癌EMT介导的他莫昔芬耐药性：勘误。
Int J Biol Sci. 2022 Aug 20;18(14):5309-5311. doi: 10.7150/ijbs.75891. eCollection 2022.
5
Erratum: Selective targeting of the TLR4 co-receptor, MD2, prevents colon cancer growth and lung metastasis: Erratum.勘误：TLR4 共受体 MD2 的选择性靶向可预防结肠癌生长和肺转移：勘误。
Int J Biol Sci. 2022 Apr 26;18(7):3102-3103. doi: 10.7150/ijbs.74103. eCollection 2022.
6
Erratum: Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma: Erratum.勘误：穿心莲内酯通过抑制胰岛素瘤中TLR4/NF-κB信号激活来抑制肿瘤生长：勘误。
Int J Biol Sci. 2020 Jun 25;16(13):2379-2381. doi: 10.7150/ijbs.49433. eCollection 2020.
7
Erratum: MiR-17-5p and MKL-1 modulate stem cell characteristics of gastric cancer cells: Erratum.勘误：MiR-17-5p与MKL-1调节胃癌细胞的干细胞特性：勘误。
Int J Biol Sci. 2022 Apr 26;18(7):3104-3106. doi: 10.7150/ijbs.73846. eCollection 2022.
8
Erratum: TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression : Erratum.勘误：TRIM59是卵巢癌预后不良的新型标志物并通过诱导膜联蛋白A2表达促进卵巢癌恶性进展：勘误。
Int J Biol Sci. 2022 Jan 1;18(3):1051. doi: 10.7150/ijbs.69329. eCollection 2022.
9
Erratum: MiR-216a-5p inhibits tumorigenesis in Pancreatic Cancer by targeting TPT1/mTORC1 and is mediated by LINC01133: Erratum.勘误：MiR-216a-5p通过靶向TPT1/mTORC1抑制胰腺癌的肿瘤发生，并由LINC01133介导：勘误。
Int J Biol Sci. 2022 Mar 3;18(5):2184-2185. doi: 10.7150/ijbs.70911. eCollection 2022.
10
Erratum: Inhibition of PERK Signaling Prevents Against Glucocorticoid-induced Endotheliocyte Apoptosis and Osteonecrosis of the Femoral Head: Erratum.勘误：抑制PERK信号通路可预防糖皮质激素诱导的内皮细胞凋亡和股骨头坏死：勘误。
Int J Biol Sci. 2021 Mar 19;17(4):1101-1102. doi: 10.7150/ijbs.58918. eCollection 2021.
引用本文的文献
1
Clinically relevant CHK1 inhibitors abrogate wild-type and Y537S mutant ERα expression and proliferation in luminal primary and metastatic breast cancer cells.临床上相关的 CHK1 抑制剂可消除野生型和 Y537S 突变型 ERα 在腔面原发性和转移性乳腺癌细胞中的表达和增殖。
J Exp Clin Cancer Res. 2022 Apr 13;41(1):141. doi: 10.1186/s13046-022-02360-y.
本文引用的文献
1
The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer.CHK1 在乳腺癌靶向治疗中对雌激素受体和孕激素受体的作用不同。
Int J Biol Sci. 2020 Feb 21;16(8):1388-1402. doi: 10.7150/ijbs.41627. eCollection 2020.
Zotero 插件